SPRUCE BIOSCIENCES INC (SPRB) Stock Analyst Earnings Estimates
NASDAQ:SPRB - Nasdaq - US85209E1091 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.089M | 5.195M -48.51% | 2.04M -60.73% | 5.61M 175.00% | 10.965M 95.45% | 2.55M -76.74% | -100.00% | 27.596M | 84.181M 205.05% | 142.64M 69.44% | |||
| EBITDA YoY % growth | -42M -42.95% | -47.21M -12.40% | -51.923M -9.98% | -72.219M -39.09% | -88.787M -22.94% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -42.07M -43.00% | -47.28M -12.38% | -51.993M -9.97% | -41.4M 20.37% | -23.444M 43.37% | -29.81M -27.15% | -58.322M -95.65% | -49.091M 15.83% | -14.687M 70.08% | 12.241M 183.35% | 66.621M 444.24% | 122.7M 84.18% | |
| Operating Margin | N/A | N/A | -515.34% | -796.91% | -1,149.21% | -531.37% | -531.89% | -1,925.12% | N/A | 44.36% | 79.14% | 86.02% | |
| EPS YoY % growth | -1.80 58.98% | -1.96 -8.89% | -1.26 35.71% | -0.96 23.64% | -0.57 40.99% | -0.61 -7.24% | -1.09 -78.39% | -1.03 5.63% | -0.14 86.07% | 0.13 192.86% | 0.60 353.85% | 1.06 76.27% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.20 15.00% | -0.26 8.93% | -0.27 -20.55% | -0.27 -26.29% | -0.15 25.00% | -0.39 -51.60% | -0.36 -35.00% | -0.39 -45.77% | -0.16 -5.33% |
| Revenue Q2Q % growth | 1.466M -49.22% | -100.00% | -100.00% | -100.00% | -100.00% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.859M 20.65% | -10.608M 16.03% | -10.914M -8.75% | -11.118M -18.18% | -11.424M -28.96% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.21 30.00% | -0.24 | 0.03 | 13.31% |
| Q2 2024 Q2Q % growth | -0.22 31.25% | -0.33 | 0.11 | 32.77% |
| Q1 2024 Q2Q % growth | -0.28 30.00% | -0.30 | 0.02 | 5.11% |
| Q4 2023 Q2Q % growth | -0.24 48.94% | -0.39 | 0.15 | 39.07% |
| Q3 2023 Q2Q % growth | -0.30 37.50% | -0.36 | 0.06 | 16.76% |
| Q2 2023 Q2Q % growth | -0.32 37.25% | -0.40 | 0.08 | 20.04% |
| Q1 2023 Q2Q % growth | -0.40 20.00% | -0.37 | -0.03 | -8.26% |
| Q4 2022 Q2Q % growth | -0.47 -20.51% | -0.54 | 0.07 | 13.06% |
| Q3 2022 Q2Q % growth | -0.48 2.04% | -0.55 | 0.07 | 12.04% |
| Q2 2022 Q2Q % growth | -0.51 -2.00% | -0.54 | 0.03 | 4.76% |
| Q1 2022 Q2Q % growth | -0.50 -19.05% | -0.47 | -0.03 | -6.95% |
| Q4 2021 Q2Q % growth | -0.39 | -0.55 | 0.16 | 29.19% |
| Q3 2021 Q2Q % growth | -0.49 96.03% | -0.58 | 0.09 | 16.09% |
| Q2 2021 Q2Q % growth | -0.50 | -0.46 | -0.04 | -8.93% |
| Q1 2021 Q2Q % growth | -0.42 | -0.43 | 0.01 | 2.73% |
| Q4 2020 Q2Q % growth | -0.39 | -0.61 | 0.22 | 35.70% |
| Q3 2020 Q2Q % growth | -12.35 | -0.52 | -11.83 | -2,274.09% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 602K -80.41% | 1.524M | -922K | -60.50% |
| Q2 2024 Q2Q % growth | 1.61M -25.64% | 1.525M | 85K | 5.57% |
| Q1 2024 Q2Q % growth | 2.002M 1.93% | 1.181M | 821K | 69.52% |
| Q4 2023 Q2Q % growth | 2.887M | 1.428M | 1.459M | 102.17% |
| Q3 2023 Q2Q % growth | 3.073M | 1.53M | 1.543M | 100.85% |
| Q2 2023 Q2Q % growth | 2.165M | 833.003K | 1.332M | 159.90% |
| Q1 2023 Q2Q % growth | 1.964M | 510K | 1.454M | 285.10% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 34.37% | 0% | 5.19% |
| Revenue | 0% | 31.36% | 3.01% | -18.1% |